发布求助
文献互助 智能选刊 最新文献

Urologie最新文献

筛选
英文 中文
AUO. AUO.
IF 0.5 4区 医学
Urologie Pub Date : 2024-10-01 DOI: 10.1007/s00120-024-02447-8
{"title":"AUO.","authors":"","doi":"10.1007/s00120-024-02447-8","DOIUrl":"https://doi.org/10.1007/s00120-024-02447-8","url":null,"abstract":"","PeriodicalId":29782,"journal":{"name":"Urologie","volume":"63 10","pages":"1083-1084"},"PeriodicalIF":0.5,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142381775","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
BvDU Kurz notiert. BvDU 简介。
IF 0.5 4区 医学
Urologie Pub Date : 2024-10-01 DOI: 10.1007/s00120-024-02452-x
{"title":"BvDU Kurz notiert.","authors":"","doi":"10.1007/s00120-024-02452-x","DOIUrl":"https://doi.org/10.1007/s00120-024-02452-x","url":null,"abstract":"","PeriodicalId":29782,"journal":{"name":"Urologie","volume":"63 10","pages":"1065-1066"},"PeriodicalIF":0.5,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142381777","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Digital care of chronic wounds]. [慢性伤口的数字化护理］
IF 0.5 4区 医学
Urologie Pub Date : 2024-10-01 Epub Date: 2024-06-06 DOI: 10.1007/s00120-024-02375-7
Sabine Bohnet-Joschko, Lara Schmidt
{"title":"[Digital care of chronic wounds].","authors":"Sabine Bohnet-Joschko, Lara Schmidt","doi":"10.1007/s00120-024-02375-7","DOIUrl":"10.1007/s00120-024-02375-7","url":null,"abstract":"","PeriodicalId":29782,"journal":{"name":"Urologie","volume":" ","pages":"1037-1039"},"PeriodicalIF":0.5,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141284964","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Rare case of leiomyosarcoma of the urinary bladder in a young man]. [一名年轻男子膀胱癌的罕见病例]。
IF 0.5 4区 医学
Urologie Pub Date : 2024-10-01 Epub Date: 2024-08-14 DOI: 10.1007/s00120-024-02418-z
Simon Filmar, A J Gross, C Tonus, S Hook, C M Rosenbaum, B Becker, C Netsch, P Gattenloehner
{"title":"[Rare case of leiomyosarcoma of the urinary bladder in a young man].","authors":"Simon Filmar, A J Gross, C Tonus, S Hook, C M Rosenbaum, B Becker, C Netsch, P Gattenloehner","doi":"10.1007/s00120-024-02418-z","DOIUrl":"10.1007/s00120-024-02418-z","url":null,"abstract":"<p><p>Leiomyosarcomas are rare, highly aggressive tumors of the urinary bladder. With approximately 200 cases reported in the literature, there is limited data on the prognosis and treatment of these neoplasms. Curative treatment approaches are primarily characterized by radical surgery, especially radical cystectomy. However, this procedure is associated with significant impairments in the quality of life for patients. This circumstance forms the basis for considering a curative treatment approach with partial cystectomy for a 19-year-old man with leiomyosarcoma of the urinary bladder.</p>","PeriodicalId":29782,"journal":{"name":"Urologie","volume":" ","pages":"1028-1032"},"PeriodicalIF":0.5,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141976811","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Bacterial vaccines for the management of recurrent urinary tract infections: a systematic review and meta-analysis]. [用于治疗复发性尿路感染的细菌疫苗：系统回顾和荟萃分析]。
IF 0.5 4区 医学
Urologie Pub Date : 2024-10-01 Epub Date: 2024-09-27 DOI: 10.1007/s00120-024-02444-x
Fabian P Stangl
{"title":"[Bacterial vaccines for the management of recurrent urinary tract infections: a systematic review and meta-analysis].","authors":"Fabian P Stangl","doi":"10.1007/s00120-024-02444-x","DOIUrl":"10.1007/s00120-024-02444-x","url":null,"abstract":"","PeriodicalId":29782,"journal":{"name":"Urologie","volume":" ","pages":"1047-1049"},"PeriodicalIF":0.5,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11458646/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142355426","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Er ist nicht weit, der Tellerrand…. 不远，盘子的边缘....
IF 0.5 4区 医学
Urologie Pub Date : 2024-10-01 DOI: 10.1007/s00120-024-02445-w
{"title":"Er ist nicht weit, der Tellerrand….","authors":"","doi":"10.1007/s00120-024-02445-w","DOIUrl":"https://doi.org/10.1007/s00120-024-02445-w","url":null,"abstract":"","PeriodicalId":29782,"journal":{"name":"Urologie","volume":"63 10","pages":"1060"},"PeriodicalIF":0.5,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142381778","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mitteilungen der DGU. 总干事室函件。
IF 0.5 4区 医学
Urologie Pub Date : 2024-10-01 DOI: 10.1007/s00120-024-02448-7
{"title":"Mitteilungen der DGU.","authors":"","doi":"10.1007/s00120-024-02448-7","DOIUrl":"https://doi.org/10.1007/s00120-024-02448-7","url":null,"abstract":"","PeriodicalId":29782,"journal":{"name":"Urologie","volume":"63 10","pages":"1061-1064"},"PeriodicalIF":0.5,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142381780","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Berufspolitik BvDU. 专业政策 BvDU。
IF 0.5 4区 医学
Urologie Pub Date : 2024-10-01 DOI: 10.1007/s00120-024-02449-6
{"title":"Berufspolitik BvDU.","authors":"","doi":"10.1007/s00120-024-02449-6","DOIUrl":"https://doi.org/10.1007/s00120-024-02449-6","url":null,"abstract":"","PeriodicalId":29782,"journal":{"name":"Urologie","volume":"63 10","pages":"1067-1080"},"PeriodicalIF":0.5,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142381776","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Paradigm shift in systemic therapy for metastatic urothelial carcinoma-antibody-drug conjugates (ADCs) and fibroblast growth factor receptor (FGFR) inhibitors]. [转移性尿路上皮癌系统疗法的范式转变--抗体药物共轭物 (ADC) 和成纤维细胞生长因子受体 (FGFR) 抑制剂]。
IF 0.5 4区 医学
Urologie Pub Date : 2024-10-01 Epub Date: 2024-09-05 DOI: 10.1007/s00120-024-02440-1
Jozefina Casuscelli, Gunhild von Amsberg, Margitta Retz
{"title":"[Paradigm shift in systemic therapy for metastatic urothelial carcinoma-antibody-drug conjugates (ADCs) and fibroblast growth factor receptor (FGFR) inhibitors].","authors":"Jozefina Casuscelli, Gunhild von Amsberg, Margitta Retz","doi":"10.1007/s00120-024-02440-1","DOIUrl":"10.1007/s00120-024-02440-1","url":null,"abstract":"<p><strong>Background: </strong>Patients with locally advanced or metastatic urothelial carcinoma face a poor prognosis. Standard first-line treatment involves platinum-based combinations followed by avelumab maintenance therapy. Follow-up therapies include enfortumab vedotin, vinflunine, and taxanes.</p><p><strong>Objective: </strong>To analyze new drug combinations in first-line and follow-up treatment for metastatic urothelial carcinoma concerning their clinical relevance, toxicities, and novel treatment sequences.</p><p><strong>Materials and methods: </strong>Analysis of new study data from EV-302/KN-A39 (enfortumab vedotin and pembrolizumab) and CheckMate-901 (nivolumab and gemcitabine-cisplatin) for untreated metastatic patients as well as TROPHY-U-01 (sacituzumab govitecan) and THOR (erdafitinib) for later lines.</p><p><strong>Results: </strong>The new standard in first-line treatment for metastatic urothelial carcinoma is the combination of enfortumab vedotin and pembrolizumab. For cisplatin-eligible patients with contraindications to enfortumab vedotin, the combination of nivolumab and gemcitabine-cisplatin offers an alternative. Erdafitinib presents a new biomarker-based option in the follow-up treatment of metastatic urothelial carcinoma.</p><p><strong>Conclusion: </strong>These novel combinations are revolutionizing the treatment standard for metastatic urothelial carcinoma and necessitate a new approach to managing side effects.</p>","PeriodicalId":29782,"journal":{"name":"Urologie","volume":" ","pages":"1002-1010"},"PeriodicalIF":0.5,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142134012","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Can muscle invasive bladder cancer be treated without cystectomy in the future? : New data on trimodal therapy and bladder preservation after systemic therapy alone]. [肌层浸润性膀胱癌今后是否可以不进行膀胱切除术？ 关于三联疗法和单纯系统疗法后膀胱保留的新数据]。
IF 0.5 4区 医学
Urologie Pub Date : 2024-10-01 Epub Date: 2024-08-14 DOI: 10.1007/s00120-024-02420-5
Jan Hausmann, Camilla M Grunewald
{"title":"[Can muscle invasive bladder cancer be treated without cystectomy in the future? : New data on trimodal therapy and bladder preservation after systemic therapy alone].","authors":"Jan Hausmann, Camilla M Grunewald","doi":"10.1007/s00120-024-02420-5","DOIUrl":"10.1007/s00120-024-02420-5","url":null,"abstract":"<p><p>Muscle invasive bladder cancer is generally an aggressive disease. Radical cystectomy (RC) is traditionally the treatment of choice. Due to possible advantages in morbidity, peri-interventional mortality, and quality of life, bladder-preserving treatment strategies are of interest. Here, trimodal therapy (TMT) consisting of maximum transurethral resection and subsequent radiochemotherapy with subsequent cystoscopic follow-up plays an important role. Current cohort analyses indicate equivalent oncological results of TMT to RC in selected patients. However, the use of systemic therapy alone with combined chemo-/immunotherapy or cytotoxic combination therapy also shows promising efficacy both in early surrogate parameters and in oncological endpoints. Overall, studies to date suggest that bladder preservation is possible without compromising oncologic outcomes. Future developments aim to refine patient selection by combining different risk factors and biomarkers to further improve outcomes.</p>","PeriodicalId":29782,"journal":{"name":"Urologie","volume":" ","pages":"985-993"},"PeriodicalIF":0.5,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141983456","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页 下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信